Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital (NCT07222410)
Closed Loop Oxygen Control in COPD Patients Treated With Nasal High Flow in the Hospital
🩺 Plain-English Summary (8th-Grade Level)
The trial aims to evaluate whether the Airvo 3 device in OptiO2 mode can maintain patients' SpO2 levels within the target range better than manual oxygen titration in hospitalized COPD patients with hypoxemia/respiratory distress.
Who can join: Review the eligibility criteria below.
Location: The University of Alabama at Birmingham — Birmingham, Alabama
Age range: 22 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- The University of Alabama at Birmingham — Birmingham, Alabama
- Central Iowa Hospital Corp - UnityPoint Health — Des Moines, Iowa
- Icahn School of Medicine at Mount Sinai — New York, New York
- Temple University Hospital — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (649) 574-0123
Email: optio2trial@fphcare.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in COPD
- Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound — Calgary,
- Impairments That Affect Correct Inhaler Use in COPD — Birmingham, Alabama
- The Development of an Integrated Physical Activity and Mental Health Intervention for Veterans With COPD, Emotion Distress, and Low Physical Activity — Boston, Massachusetts
- A Study to Evaluate Solrikitug in Participants With COPD (ZION) — Birmingham, Alabama
- RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD — Calgary, Alberta
- Evaluation of the Safety and Efficacy of TLD in Patients with COPD — Birmingham, Alabama
Explore by condition: All COPD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.